These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37914665)

  • 1. Ingenious Synergy of a Pathology-Specific Biomimetic Multifunctional Nanoplatform for Targeted Therapy in Rheumatoid Arthritis.
    Xu H; Wang Y; Rong X; Wang D; Xie J; Huang Z; Zeng W; Fu X; Li J; Zhou Z
    Small; 2024 Mar; 20(10):e2305197. PubMed ID: 37914665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-loaded pH/ROS dual-responsive nanoparticles alleviate joint destruction by downregulating the NF-κB signaling pathway.
    Lu Y; Zhou J; Wang Q; Cai J; Yu B; Dai Q; Bao Y; Chen R; Zhang Z; Zhang D; Hou T
    Acta Biomater; 2023 Jul; 164():458-473. PubMed ID: 37072065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted co-delivery biomimetic nanoparticles reverse macrophage polarization for enhanced rheumatoid arthritis therapy.
    Zheng X; Yu X; Wang C; Liu Y; Jia M; Lei F; Tian J; Li C
    Drug Deliv; 2022 Dec; 29(1):1025-1037. PubMed ID: 35363114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic nanoparticles for effective Celastrol delivery to targeted treatment of rheumatoid arthritis through the ROS-NF-κB inflammasome axis.
    Wang B; Shen J; Wang X; Hou R
    Int Immunopharmacol; 2024 Apr; 131():111822. PubMed ID: 38503010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
    Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
    Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Oxygen Generation and Reactive Oxygen Species Scavenging by Manganese Ferrite/Ceria Co-decorated Nanoparticles for Rheumatoid Arthritis Treatment.
    Kim J; Kim HY; Song SY; Go SH; Sohn HS; Baik S; Soh M; Kim K; Kim D; Kim HC; Lee N; Kim BS; Hyeon T
    ACS Nano; 2019 Mar; 13(3):3206-3217. PubMed ID: 30830763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways.
    Li CH; Ma ZZ; Jian LL; Wang XY; Sun L; Liu XY; Yao ZQ; Zhao JX
    Int Immunopharmacol; 2021 Jan; 90():107219. PubMed ID: 33307512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive CCL2/CCR2 Axis Blockade Suppresses Osteoclast Activity in a Mouse Model of Rheumatoid Arthritis by Reducing Homing of CCR2
    Flegar D; Filipović M; Šućur A; Markotić A; Lukač N; Šisl D; Ikić Matijašević M; Jajić Z; Kelava T; Katavić V; Kovačić N; Grčević D
    Front Immunol; 2021; 12():767231. PubMed ID: 34925336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis.
    Shimizu T; Takahata M; Kameda Y; Endo T; Hamano H; Hiratsuka S; Ota M; Iwasaki N
    Bone; 2015 Oct; 79():65-70. PubMed ID: 26027508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARD6 protects against collagen-induced rheumatoid arthritis in mice through attenuating the inflammatory response and joint destruction via suppression of TNFR1/TRAF2 signaling.
    Zhao M; He H; Yin J
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1092-1099. PubMed ID: 32317187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphyllin I Ameliorates Collagen-Induced Arthritis by Suppressing the Inflammation Response in Macrophages Through the NF-κB Pathway.
    Wang Q; Zhou X; Zhao Y; Xiao J; Lu Y; Shi Q; Wang Y; Wang H; Liang Q
    Front Immunol; 2018; 9():2091. PubMed ID: 30319603
    [No Abstract]   [Full Text] [Related]  

  • 12. Excavatolide B Attenuates Rheumatoid Arthritis through the Inhibition of Osteoclastogenesis.
    Lin YY; Jean YH; Lee HP; Lin SC; Pan CY; Chen WF; Wu SF; Su JH; Tsui KH; Sheu JH; Sung PJ; Wen ZH
    Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28067799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization.
    Yang Y; Guo L; Wang Z; Liu P; Liu X; Ding J; Zhou W
    Biomaterials; 2021 Jan; 264():120390. PubMed ID: 32980634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-Mimetic, ROS Responsive, and Oxygen Generating Nanovesicles for Targeted Interventions of Refractory Rheumatoid Arthritis.
    Tang Z; Meng S; Yang X; Xiao Y; Wang W; Liu Y; Wu K; Zhang X; Guo H; Zhu YZ; Wang X
    Small; 2024 May; 20(20):e2307379. PubMed ID: 38084463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
    Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
    Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of p-coumaric acid encapsulated mannosylated liposomes to the synovial macrophages inhibits osteoclast formation and bone resorption in the rheumatoid arthritis animal model.
    Neog MK; Rasool M
    Eur J Pharm Biopharm; 2018 Dec; 133():162-175. PubMed ID: 30339889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
    Cejka D; Hayer S; Niederreiter B; Sieghart W; Fuereder T; Zwerina J; Schett G
    Arthritis Rheum; 2010 Aug; 62(8):2294-302. PubMed ID: 20506288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic Epigallocatechin Gallate-Cerium Assemblies for the Treatment of Rheumatoid Arthritis.
    Song X; Zheng Z; Ouyang S; Chen H; Sun M; Lin P; Chen Y; You Y; Hao W; Tao J; Zhao P
    ACS Appl Mater Interfaces; 2023 Jul; 15(28):33239-33249. PubMed ID: 37399544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis.
    Vattakuzhi Y; Abraham SM; Freidin A; Clark AR; Horwood NJ
    Arthritis Rheum; 2012 Jul; 64(7):2201-10. PubMed ID: 22275313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necessity of lysophosphatidic acid receptor 1 for development of arthritis.
    Miyabe Y; Miyabe C; Iwai Y; Takayasu A; Fukuda S; Yokoyama W; Nagai J; Jona M; Tokuhara Y; Ohkawa R; Albers HM; Ovaa H; Aoki J; Chun J; Yatomi Y; Ueda H; Miyasaka M; Miyasaka N; Nanki T
    Arthritis Rheum; 2013 Aug; 65(8):2037-47. PubMed ID: 23666827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.